Global Transplantation Market Size study & Forecast, by Product (Tissue Products, Immunosuppressive Drugs Preservation Solution) by Application (Organ Transplantation, Tissue Transplantation), by End User (Hospitals, Transplant Centers, Others) and Region

Global Transplantation Market Size study & Forecast, by Product (Tissue Products, Immunosuppressive Drugs Preservation Solution) by Application (Organ Transplantation, Tissue Transplantation), by End User (Hospitals, Transplant Centers, Others) and Regional Analysis, 2022-2029

Global Transplantation Market is valued at approximately USD 12.4 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.4% over the forecast period 2022-2029. Transplantation is referred as a surgical method in which an organ is detached from an individual’s body and placed in the recipient’s body. There are two common type of transplantation are performed that are tissue transplantation and organ transplantation. The rising cases of organ failure, a growing development of tissue banks, coupled with the reimbursement framework are the primary factors that are stipulating the market demand across the globe.

The demand for transplantation procedures is constantly growing owing to the high incidences of chronic diseases and related organ failure. As per the Department of Health & Human Services, approximately 122,913 patients across the United States waiting to receive organs for transplant in 2019. Likewise, the preliminary data from the Organ Procurement and Transplantation Network (OPTN) reported that, in 2021, it was estimated that there were around 41,354 organ transplants were performed in the U.S., which is a rise of 5.9% compared to 2020. Thus, the growing requirement for transplantation procedures among the population is fueling the market demand across the globe. Moreover, the rising technological advancements in tissue products, as well as the increasing FDA approvals for new indications are presenting various lucrative opportunities over the forecasting years. However, the scarcity of organ donors and ethical and cultural issues are poised to hinder market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Transplantation Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue because of the well-developed healthcare facilities and the presence of many large biotechnology and medical device companies in the local market. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to increased research on stem cells for the development of in-vitro tissue and organs, as well as developing healthcare infrastructure in Asian countries.

Major market players included in this report are:
Abbvie, Inc
Arthrex, Inc.
Zimmer Biomet
Medtronic
Novartis AG
Strykers
21st Century Medicine
BiolifeSolutions, Inc
Teva Pharmaceuticals
Veloxis Pharmaceutical

Recent Developments in the Market:
 In January 2022, Novartis AG partnered with Alnylam to investigate targeted therapy to restore liver function. Alnylam's siRNA technology is intended to promote the regrowth of functional liver cells and is an option for patients suffering from liver failure.
 In January 2022, BioLife Solutions extended its partnership with Seattle Children's Therapeutics to optimise bio preservation and closed-system manufacturing by incorporating Sexton's AF-500 cell processing tools.

Global Transplantation Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Application, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:

By Product:
Tissue Products
Immunosuppressive Drugs
Preservation Solution
By Application:
Organ Transplantation
Tissue Transplantation
By End User:
Hospitals
Transplant Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World




Companies Mentioned

Abbvie, Inc
Arthrex, Inc.
Zimmer Biomet
Medtronic
Novartis AG
Strykers
21st Century Medicine
BiolifeSolutions, Inc
Teva Pharmaceuticals
Veloxis Pharmaceutical

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.